Literature DB >> 27358851

Isolated factor V deficiency in a patient with elevated PT and aPTT during routine pre-operative laboratory screening.

Keyur Thakar1, Kaushal Parikh1, Yamei Chen1, Delong Liu1.   

Abstract

Isolated factor V (FV) deficiency is a rare disorder with approximately 150 cases reported in the literature since 1943. Bleeding symptoms from FV deficiency vary widely. FV deficiency usually manifests early in the life. We present a 59-year-old case with FV deficiency discovered during pre-operative laboratory screen.

Entities:  

Keywords:  Factor V deficiency (FV deficiency); coagulopathy; hemostasis

Year:  2014        PMID: 27358851      PMCID: PMC4923507          DOI: 10.3978/j.issn.2306-9759.2014.03.02

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


  17 in total

Review 1.  Factor V: a combination of Dr Jekyll and Mr Hyde.

Authors:  Kenneth G Mann; Michael Kalafatis
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

2.  Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis.

Authors:  Eric Chun-Yet Lian; Andreas G Tzakis; David Andrews
Journal:  Am J Hematol       Date:  2004-12       Impact factor: 10.047

3.  Rare bleeding disorders.

Authors:  Flora Peyvandi; Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2009-07-13       Impact factor: 4.180

4.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

Authors:  M E Nesheim; J B Taswell; K G Mann
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

5.  Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.

Authors:  Connie Duckers; Paolo Simioni; Luca Spiezia; Claudia Radu; Paolo Dabrilli; Sabrina Gavasso; Jan Rosing; Elisabetta Castoldi
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

6.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

7.  Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.

Authors:  S S Acharya; A Coughlin; D M Dimichele
Journal:  J Thromb Haemost       Date:  2004-02       Impact factor: 5.824

8.  Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency.

Authors:  D Delev; A Pavlova; S Heinz; E Seifried; J Oldenburg
Journal:  Haemophilia       Date:  2009-05-26       Impact factor: 4.287

9.  High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.

Authors:  Emmanuelle de Raucourt; Christophe Barbier; Patrick Sinda; Mamoun Dib; Jean-Yves Peltier; Catherine Ternisien
Journal:  Am J Hematol       Date:  2003-11       Impact factor: 10.047

10.  Successful treatment with rituximab in a patient with an acquired factor V inhibitor.

Authors:  Agnes Lebrun; Catherine Leroy-Matheron; Jean-Benoit Arlet; Pablo Bartolucci; Marc Michel
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

View more
  2 in total

1.  Successful coronary stenting in a patient with factor V deficiency in the absence of fresh frozen plasma transfusion: Case report.

Authors:  Seongil Choi; MooKon Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

2.  Aortic Valve Replacement in Severe Factor V Deficiency and Inhibitor: Diagnostic and Management Challenges.

Authors:  Alexa Bello; Eric Salazar; Kirk Heyne; Joseph Varon
Journal:  Cureus       Date:  2019-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.